ロード中...
Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia
The epidermal growth factor receptor (EGFR) inhibitor erlotinib has been shown to induce complete remission of acute myeloid leukemia (AML) in two patients with concurrent lung cancer and raised attention for a role of EGFR in AML whereas a recent phase II clinical study with gefitinib in AML demons...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971659/ https://ncbi.nlm.nih.gov/pubmed/27488458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0294-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|